Importantly, Mfn2 inhibition was recently reported to prevent diabetic cardiomyopathy (Hu et al., 2019), although this effect was primarily attributed to the suppression of Mfn2-induced mitochondrial fusion. This evidence concerns the gene MFN2 and diabetic cardiomyopathy.